 |
市场调查报告书
商品编码
1689941
生物活性材料：市场占有率分析、行业趋势和统计数据、成长预测（2025-2030 年）Bioactive Materials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) |
||||||
价格
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
简介目录
生物活性材料市场规模预计在 2025 年为 30.4 亿美元，预计到 2030 年将达到 60.9 亿美元，预测期内（2025-2030 年）的复合年增长率为 14.88%。
由于这种材料广泛应用于医疗保健行业，COVID-19 对市场产生了积极影响，对医疗保健设备的需求大幅增加。
从长远来看，预计市场将受到牙科治疗和根管治疗需求成长的推动。
主要亮点
- 高成本、法规和潜在毒性是市场成长的主要障碍。
- 预计整形外科不断增长的需求和新发展将为市场创造机会。
- 预计在预测期内北美将占据市场主导地位。
生物活性材料市场趋势
整形外科的需求不断增加
- 生物活性材料刺激身体的生物反应，例如与组织结合。生物活性材料可应用于奈米医学、生物感测器、机械联锁、骨组织癒合、牙科等领域。
- 在整形外科中，羟磷石灰是最常用的生物活性陶瓷材料。生物活性材料在植入表面形成生理活性层，从而将材料与天然组织连接起来。透过改变生物活性材料的组成，可以改变界面结合层的结合率和厚度。
- 儘管生物活性玻璃在体内具有很高的生物活性，但与金属植入相比，生物活性玻璃在整形外科手术中的作用有限。生物活性玻璃是一种有望应用于外科骨科领域的新型材料。
- 根据欧盟统计局的数据，到2021年，欧盟五分之一的人口（20.8%）将超过65岁。 2021年至2100年间，欧盟80岁以上人口比例预计将增加一倍以上，从6.0%增加至14.6%。
- 根据印度国家统计局（NSO）《2021年印度老年人口研究》显示，印度老年人口（60岁以上）预计在2031年达到1.94亿，比2021年的1.38亿增加41%。
- 预计所有这些因素将在预测期内推动整形外科领域对生物活性材料的需求。
北美占据市场主导地位
- 由于美国持续投资于高度发展的医疗保健和医疗技术领域，预计北美将主导全球市场。
- 美国医疗保健产业是该地区最先进的产业之一。根据医疗保险和医疗补助服务中心的数据，预计2021年至2028年期间全国医疗保健支出的平均成长率将超过5.5%，到2028年将达到约6.192兆美元。
- 生物活性材料应用于根管治疗、骨缺损治疗、牙齿再生、硬组织修復、干细胞移植等领域，生物活性玻璃和微晶玻璃是骨组织工程应用的主要生物活性材料。
- 根据世界银行的数据，美国65岁以上人口约占总人口的16.6%。 65 岁以上的老年人需要更频繁地就诊以治疗蛀牙和牙龈问题，并且关节炎的风险也更高。
- 根据美国整形外科学会 (AAOS) 的统计，肌肉骨骼疾病和关节（膝关节和髋关节）置换术是美国人最常见的手术。这些应用中生物活性材料的使用越来越多。
- 2022年，加拿大医疗保健总支出价值2,457.2亿美元，预计今年底将达到2,645亿美元。在医疗保健产业中，医疗设备产业是一个高度多样化、出口导向的产业，生产设备和消耗品。该行业由产品创新推动。该行业能够利用加拿大大学、研究机构和医院进行的世界级的创新研究，其中一些研究成果被分拆为加拿大医疗设备公司。
- 进行手术需要先进的医疗设备和零件，包括生物活性材料。预计这项措施以及这些材料在製药领域的应用将在未来几年推动北美生物活性材料市场的发展。
生物活性材料产业概况
全球生物活性材料产业较为分散，主要企业占大部分市场份额。主要企业包括（排名不分先后）：波士顿科学公司、Depuy Synthes、赢创工业公司、DSM 和 Arthrex。
其他福利
- Excel 格式的市场预测 (ME) 表
- 3个月的分析师支持
目录
第一章 引言
- 调查前提条件
- 研究范围
第二章调查方法
第三章执行摘要
第四章 市场动态
- 驱动程式
- 牙科治疗和根管治疗的需求不断增加
- 在医疗产业的应用日益广泛
- 限制因素
- 高成本、法规严格、潜在毒性
- 产业价值链分析
- 波特五力分析
- 新进入者的威胁
- 买家的议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争程度
第五章市场区隔
- 依材料类型
- 生物活性玻璃
- 生物活性陶瓷
- 生物活性复合材料
- 其他的
- 按应用
- 整形外科
- 牙科
- 奈米医学和生物技术
- 其他的
- 按地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
- 北美洲
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 其他欧洲国家
- 南美洲
- 巴西
- 阿根廷
- 南美洲其他地区
- 中东和非洲
- 沙乌地阿拉伯
- 南非
- 其他中东和非洲地区
- 亚太地区
第六章竞争格局
- 併购、合资、合作与协议
- 市场排名分析
- 主要企业策略
- 公司简介
- Arthrex Inc.
- Bioactive Bone Substitutes OyJ
- Biomatlante
- BTG（Boston Scientific）
- Cam Bioceramics
- Ceraver
- Collagen Matrix Inc.
- DePuy Synthes（Johnson and Johnson）
- DSM
- Evonik Industries
- Medtronic Inc.
- Noraker
- OSARTIS GmbH
- Pulpdent Corporation
- Septodont Holding
- Stryker Corporation
- Zimmer Holdings Inc.
第七章 市场机会与未来趋势
- 整形外科需求的不断成长与新开发
简介目录
Product Code: 69445
The Bioactive Materials Market size is estimated at USD 3.04 billion in 2025, and is expected to reach USD 6.09 billion by 2030, at a CAGR of 14.88% during the forecast period (2025-2030).
As the material is widely used in the healthcare industry, COVID-19 had a positive impact on the market, as the demand for healthcare equipment grew significantly.
Over the long term, the growing demand for dental care and root canal treatment will drive the market.
Key Highlights
- On the flip side, high costs, regulations, and probable toxicity hinder market growth significantly.
- The rising demand for orthopedics and new developments are expected to create opportunities for the market studied.
- North America is expected to dominate the market during the forecast period.
Bioactive Materials Market Trends
Growing Demand from Orthopedics
- Bioactive materials stimulate a biological response from the body, such as bonding to the tissue. Bioactive materials find their application in nanomedicine and biosensors, mechanical interlocks, bone tissue healings, and dental, amongst others.
- In orthopedic surgery, hydroxyapatite is the most commonly utilized bioactive ceramic material. Bioactive materials create a physiologically active layer on the implant's surface, resulting in a link between the native tissues and the substance. Changing the composition of the bioactive material allows a wide variety of bonding rates and interfacial bonding layer thickness.
- Bioactive glasses, despite their higher bioactivity within the body, serve a minor role in orthopedic surgery compared to metallic implants. Bioactive glass is a new material that has the potential to be employed in surgical orthopedics.
- According to Eurostat, in 2021, a fifth of the EU population (20.8%) was 65 or older. Between 2021 and 2100, the proportion of people aged 80 and up in the EU's population is expected to more than double, from 6.0% to 14.6%.
- According to the National Statistical Office's (NSO) Old in India 2021 study, India's elderly population (aged 60 and more) is expected to reach 194 million in 2031, up by 41% from 138 million in 2021.
- All such factors are expected to drive the demand for bioactive materials in the orthopedics sector during the forecast period.
North America Region to Dominate the Market
- North America is expected to dominate the global market due to the highly developed healthcare sector in the United States and the continuous investments to advance the medical technology sector.
- The healthcare sector in the United States is one of the most advanced in the region. According to the Centers for Medicare and Medicaid Services, during 2021-2028, national healthcare spending is projected to grow at an average of more than 5.5% and reach approximately USD 6.192 trillion by 2028.
- Bioactive materials are used in root canal and bone defect treatment, tooth regeneration, hard tissue repairs, and stem cell transplantation. Bioactive glasses and glass ceramics are major bioactive materials used in bone tissue engineering.
- According to World Bank data, the population above 65 years of age in the United States stood at around 16.6% of the total population. They require more medical attention for tooth decay and gum problems and pose a higher risk of arthritis.
- According to the American Academy of Orthopedic Surgeons (AAOS), musculo skeletal diseases and replacement of joints (knee and hip) are the most common surgeries among the American population. These applications increasingly use bioactive materials.
- In 2022, total health expenditure in Canada was valued at USD 245.72 billion and is expected to reach USD 264.5 billion by end of this year. In the healthcare industry, the medical device sector is a highly diversified and export-oriented industry that manufactures equipment and supplies. The sector is driven by product innovations. The industry can draw on world-class innovative research conducted in Canadian universities, research institutes, and hospitals, some of which are spun off into Canadian medical device companies.
- Performing surgeries requires advanced medical devices and components, including bioactive materials.This, along with the use of these materials in pharmaceutical, is expected to drive the market for bioactive materials through the years to come in North America.
Bioactive Materials Industry Overview
The global bioactive materials industry is fragmented, with the top players accounting for a major share of the market. Some major companies are Boston Scientific, Depuy Synthes, Evonik Industries, DSM, and Arthrex, among others (not in any particular order).
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Drivers
- 4.1.1 Growing Demand for Dental Care and Root Canal Treatment
- 4.1.2 Increasing Applications in Medical Industry
- 4.2 Restraints
- 4.2.1 High Cost, Regulations, and Probable Toxicity
- 4.3 Industry Value Chain Analysis
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Degree of Competition
5 MARKET SEGMENTATION (Market Size in Revenue)
- 5.1 Material Type
- 5.1.1 Bioactive Glass
- 5.1.2 Bioactive Ceramics
- 5.1.3 Bioactive Composites
- 5.1.4 Other Material Types
- 5.2 Application
- 5.2.1 Orthopedics
- 5.2.2 Dental Care
- 5.2.3 Nanomedicines and Biotechnology
- 5.2.4 Other Applications
- 5.3 Geography
- 5.3.1 Asia-Pacific
- 5.3.1.1 China
- 5.3.1.2 India
- 5.3.1.3 Japan
- 5.3.1.4 South Korea
- 5.3.1.5 Rest of Asia-Pacific
- 5.3.2 North America
- 5.3.2.1 United States
- 5.3.2.2 Canada
- 5.3.2.3 Mexico
- 5.3.3 Europe
- 5.3.3.1 Germany
- 5.3.3.2 United Kingdom
- 5.3.3.3 France
- 5.3.3.4 Italy
- 5.3.3.5 Rest of Europe
- 5.3.4 South America
- 5.3.4.1 Brazil
- 5.3.4.2 Argentina
- 5.3.4.3 Rest of South America
- 5.3.5 Middle East and Africa
- 5.3.5.1 Saudi Arabia
- 5.3.5.2 South Africa
- 5.3.5.3 Rest of Middle East and Africa
- 5.3.1 Asia-Pacific
6 COMPETITIVE LANDSCAPE
- 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
- 6.2 Market Ranking Analysis
- 6.3 Strategies Adopted by Leading Players
- 6.4 Company Profiles
- 6.4.1 Arthrex Inc.
- 6.4.2 Bioactive Bone Substitutes OyJ
- 6.4.3 Biomatlante
- 6.4.4 BTG (Boston Scientific)
- 6.4.5 Cam Bioceramics
- 6.4.6 Ceraver
- 6.4.7 Collagen Matrix Inc.
- 6.4.8 DePuy Synthes (Johnson and Johnson)
- 6.4.9 DSM
- 6.4.10 Evonik Industries
- 6.4.11 Medtronic Inc.
- 6.4.12 Noraker
- 6.4.13 OSARTIS GmbH
- 6.4.14 Pulpdent Corporation
- 6.4.15 Septodont Holding
- 6.4.16 Stryker Corporation
- 6.4.17 Zimmer Holdings Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
- 7.1 Rising Demand from Orthopedics and New Developments
